Noramco is a world leader in specialty active pharmaceutical ingredients, with a particular focus in controlled substances. The Company’s headquarters and primary production facility is in Wilmington DE, with additional sites in Athens, GA and Neuhausen, Switzerland.

SK Capital acquired Noramco and Tasmanian Alkaloids from Johnson & Johnson in July, 2016.

For more information, please visit: www.noramco.com